Reditux® 500mg Injection – Rituximab Monoclonal Antibody Cancer & Autoimmune Therapy

Price range: 180 $ through 5 500 $

Product Overview Reditux® 500mg Injection is a premium monoclonal antibody medication containing Rituximab, widely used in the treatment of certain cancers and autoimmune disorders. Supplied in sterile vial packaging, Reditux works by targeting specific B-cells in the immune system, helping slow or stop the progression of disease while improving treatment outcomes in eligible patients. Manufactured to high pharmaceutical standards, Reditux is commonly prescribed for conditions such as Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis, and other immune-related disorders under specialist supervision. Product Details Attribute Information Brand Name Reditux® Generic Name Rituximab Dosage Strength 500mg Dosage Form Injection Packaging Type…

Category:

Description

Product Overview

Reditux® 500mg Injection is a premium monoclonal antibody medication containing Rituximab, widely used in the treatment of certain cancers and autoimmune disorders. Supplied in sterile vial packaging, Reditux works by targeting specific B-cells in the immune system, helping slow or stop the progression of disease while improving treatment outcomes in eligible patients.

Manufactured to high pharmaceutical standards, Reditux is commonly prescribed for conditions such as Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis, and other immune-related disorders under specialist supervision.


Product Details

Attribute Information
Brand Name Reditux®
Generic Name Rituximab
Dosage Strength 500mg
Dosage Form Injection
Packaging Type Vial
MOQ 1 Vial
Supply Type Exporter, Supplier, Trader
Application Oncology & Autoimmune Therapy
Preferred Buyer Location Worldwide

Uses of Reditux® 500mg Injection

Reditux is commonly used for the treatment of:

  • Non-Hodgkin’s Lymphoma (NHL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Rheumatoid Arthritis
  • Autoimmune Disorders
  • Certain Blood Cancers
  • Immune System Disorders

Mechanism of Action

Reditux (Rituximab) works by targeting the CD20 protein found on certain B-cells. It helps the immune system identify and destroy abnormal or cancerous cells, slowing disease progression and supporting treatment effectiveness.


Administration

  • Administered intravenously by healthcare professionals
  • Dosage and treatment schedule depend on patient condition and medical protocol
  • Used under strict medical supervision in hospitals and oncology clinics

Possible Side Effects

Common Side Effects

  • Fever and chills
  • Weakness or fatigue
  • Nausea
  • Headache
  • Mild allergic reactions

Serious Side Effects

  • Breathing difficulties
  • Severe infusion reactions
  • Low blood cell counts
  • Increased infection risk

Patients should remain under medical observation during treatment.


Why Choose Reditux®?

✔ Trusted Rituximab therapy
✔ High-quality oncology medication
✔ Worldwide shipping available
✔ Suitable for hospitals and oncology centers
✔ Secure pharmaceutical packaging
✔ Bulk and wholesale supply available

Additional information

Quantity

Reditux® 100mg Injection – 1 Vial Single Vial, Reditux® 500mg Injection – 1 Vial Single Vial, Reditux® 500mg Injection – 5 Vials Bulk Pack, Reditux® 500mg Injection – 10 Vials Wholesale Pack

Reviews

There are no reviews yet.

Be the first to review “Reditux® 500mg Injection – Rituximab Monoclonal Antibody Cancer & Autoimmune Therapy”

Your email address will not be published. Required fields are marked *